Enlivex Ltd (ENLV) Straddle

Trading a ENLV straddle lets you take a pure volatility position on Enlivex Ltd without committing to a direction. Enlivex Ltd's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ENLV straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on ENLV profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Enlivex Ltd stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ENLV straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the ENLV straddle is the cleanest expression of that view. Our scanner prices every ENLV straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ENLV straddle into a catalyst or short a ENLV straddle to harvest decay, the options straddle setups that matter are all in one place.